|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$1,001||Benefits minus costs||$1,643|
|Participants||$33||Benefit to cost ratio||$11.32|
|Others||$217||Chance the program will produce|
|Indirect||$552||benefits greater than the costs||50 %|
|Net program cost||($159)|
|Benefits minus cost||$1,643|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Major depressive disorder
Clinical diagnosis of major depression or symptoms measured on a validated scale.
Admission to a psychiatric ward or hospital.
An attempt to die by suicide resulting in survival.
Thinking about and/or planning death by suicide.
A positive motivational state, as measure on a validated scale such as the Kadzin Hopelessness Scale for Children.
Symptoms of self-harming behavior (such as cutting or burning) measured using a validated assessment tool.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Major depressive disorder||K-12 grade repetition||$29||$0||$0||$15||$44|
|Labor market earnings associated with major depression||$0||$0||$0||$0||$0|
|Mortality associated with depression||$8||$20||$0||$136||$163|
|Hospitalization (psychiatric)||Health care associated with psychiatric hospitalization||$963||$13||$217||$481||$1,674|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($80)||($80)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$2,792||2016||Present value of net program costs (in 2018 dollars)||($159)|
|Comparison costs||$2,641||2016||Cost range (+ or -)||25 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Katz, L.Y., Cox, B.J., Gunasekara, S., & Miller, A.L. (2004). Feasibility of dialectical behavior therapy for suicidal adolescent inpatients. Journal of the American Academy of Child and Adolescent Psychiatry, 43(3), 276-282.
Mehlum, L., Tørmoen, A.J., Ramberg, M., Haga, E., Diep, L.M., Laberg, S., . . . Grøholt, B. (2014). Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 53(10), 1082-1091.
Mehlum, L., Ramberg, M., Tormoen, A.J., Haga, E., Diep, L.M., Stanley, B.H., . . . Sund, A.M. (2016). Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: Outcomes over a one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 55(4), 295-300.
Rathus, J.H., & Miller, A.L. (2002). Dialectical behavior therapy adapted for suicidal adolescents. Suicide and Life Threatening Behavior, 32, 146-157.